Recent Finacing
Recent Raise
Alvine Pharmaceuticals is a clinical-stage biopharmaceutical developing ALV003, an investigational protease therapy for celiac disease, and conducting Phase 2a clinical trials for autoimmune and gastrointestinal indications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors